Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8.

Hernandez-Caballero, Ana I; Vierkoetter, Koah R; Ahn, Hyeong Jun; Shimizu, David; Terada, Keith

Hernandez-Caballero, Ana I; Vierkoetter, Koah R; Ahn, Hyeong Jun; Shimizu, David; Terada, Keith.

Afiliação

Hernandez-Caballero AI; University of Hawaii, John A. Burns School of Medicine, Department of Pathology, 1301 Punchbowl Street, Honolulu 96813, HI, USA.
Vierkoetter KR; University of Hawaii, John A. Burns School of Medicine, Department of Pathology, 1301 Punchbowl Street, Honolulu 96813, HI, USA.
Ahn HJ; University of Hawaii, John A. Burns School of Medicine, Department of Quantitative Health Sciences, 651 Ilalo Street, Medical Education Building, Suite 411, Honolulu 96813, HI, USA.
Shimizu D; University of Hawaii, John A. Burns School of Medicine, Department of Pathology, 1301 Punchbowl Street, Honolulu 96813, HI, USA.
Terada K; University of Hawaii, John A. Burns School of Medicine, Department of Obstetrics, Gynecology and Women's Health, 1301 Punchbowl Street, Honolulu 96813, HI, USA.

Gynecol Oncol Rep ; 33: 100614, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32775591

Palavras-chave

CAIX; Endocervical adenocarcinoma; Endometrial adenocarcinoma; Immunohistochemistry; PAX8

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google